SCHEMBL6507985

SCHEMBL6507985

Cc1nc(NC(N)=NCc2ccc(-c3ccccc3)cc2)nc2c1CCCC2

nearest known ligand 0.47

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 3/20 0.47
RAB9A P51151 3/20 0.47
SMN1; SMN2 Q16637 3/20 0.47
MEN1 O00255 1/20 0.47
KMT2A Q03164 1/20 0.47
ATP4A P20648 11/20 0.41
ATP4B P51164 11/20 0.41
L3MBTL1 Q9Y468 1/20 0.40
POLB P06746 1/20 0.39
MAPT P10636 2/20 0.39
TP53 P04637 1/20 0.39
GAA P10253 1/20 0.39
PKM P14618 1/20 0.39
SIGMAR1 Q99720 1/20 0.39
BCHE P06276 1/20 0.38
ACHE P22303 1/20 0.38
BACE1 P56817 1/20 0.38
GRIN2B Q13224 1/20 0.38
TPH1 P17752 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6511304 0.85 MAPT (0.45) NPC1RAB9ASMN1; SMN2MEN1KMT2A
SCHEMBL6507318 0.84 RAB9A (0.46) NPC1RAB9ASMN1; SMN2MEN1KMT2A
SCHEMBL6509392 0.80 MAPT (0.43) NPC1RAB9ASMN1; SMN2MEN1KMT2A
SCHEMBL6510261 0.80 LMNA (0.52) NPC1RAB9ASMN1; SMN2MEN1KMT2A
SCHEMBL6508538 0.79 RAB9A (0.74) NPC1RAB9ASMN1; SMN2MEN1KMT2A
SCHEMBL6514076 0.79 ADORA2A (0.52) NPC1RAB9ASMN1; SMN2KMT2AATP4A
SCHEMBL5923387 0.77 ACHE (0.49) NPC1RAB9ASMN1; SMN2MEN1KMT2A
SCHEMBL6513739 0.76 SMN1; SMN2 (0.42) NPC1RAB9ASMN1; SMN2MEN1KMT2A
SCHEMBL5922963 0.75 MAPT (0.41) NPC1RAB9ASMN1; SMN2MEN1KMT2A
SCHEMBL6508660 0.72 MAPK1 (0.52) NPC1RAB9ASMN1; SMN2MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005095345-A2 HETEROARYL GUANIDINES AS INHIBITORS OF VIRAL REPLICATION ACHILLION PHARMACEUTICALS, INC. (US) 2005-10-13 WO claimed